Arkolith/Insider Trading/KROS/Form 4

Schneeberger Daniel

10% OwnerKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Oct 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$95.7M
Net Open-Market Flow
-$95.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)255K$17.75$4.5M0
Oct 15, 2025Sell(S)4.4M$17.75$77.9M0
Oct 15, 2025Sell(S)743K$17.75$13.2M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-004411) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML